Target intelligence / Profile preview

Pertussis vaccine antigens (aP antigens) (aP antigens)

Target
aP antigens
Molecular classification
Bacterial antigen, Virulence factor, Adhesin, Bacterial toxin
01

Overview

Pertussis vaccine antigens are the primary active components of modern acellular pertussis (aP) vaccines, designed to provide protective immunity against Bordetella pertussis, the causative agent of whooping cough [10, 15]. These antigens typically consist of a combination of purified bacterial proteins, most commonly pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), and fimbriae types 2 and 3 (FIM2/3) [2, 16]. PT is a major virulence factor that disrupts host cell signaling, while FHA, PRN, and FIM are critical adhesins that facilitate bacterial attachment to the ciliated respiratory epithelium [5, 18]. By presenting these specific proteins to the immune system, the vaccine elicits a targeted response involving the production of neutralizing antibodies and the activation of Th1, Th2, and Th17 cellular pathways [3, 10]. This immune response prevents the severe clinical manifestations of pertussis and aids in the clearance of the bacteria from the respiratory tract [1, 14]. Despite their high safety profile compared to older whole-cell vaccines, acellular antigens are associated with more rapid waning of immunity and have led to the selection of antigen-deficient escape strains in some populations [4, 12]. These antigens are almost exclusively administered as part of multivalent combination vaccines, such as DTaP for children and Tdap for adolescents and adults [8, 20].

Other names
Bordetella pertussis antigensAcellular pertussis antigensPertussis toxinFilamentous hemagglutininPertactinFimbriaeWhooping cough vaccine components
02

Mechanism of action

The mechanism of action involves the induction of an active immune response, where the body develops specific antibodies and memory T-cells against the included antigens [2]. Antibodies against pertussis toxin (PT) neutralize its systemic effects, while antibodies against adhesins like filamentous hemagglutinin (FHA), pertactin (PRN), and fimbriae (FIM) inhibit the attachment of Bordetella pertussis to the respiratory epithelium and promote bacterial clearance through opsonophagocytosis and complement-mediated lysis [1, 10].

03

Biological functions

Immune responseBacterial adhesionToxin neutralizationPhagocytosisCell-mediated immunity
04

Disease associations

InfectionPertussis
05

Safety considerations

Waning immunityInjection site reactionsFeverFebrile seizuresHypotonic-hyporesponsive episodes (HHE)Vaccine-escape mutants (e.g., pertactin-deficient strains)
06

Interacting drugs

DTaP (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

10 more in the full profile.

07

Biomarkers

Anti-pertussis toxin IgGAnti-filamentous hemagglutinin IgGAnti-pertactin IgGAnti-fimbriae IgG

Beyond the preview

Go deeper on Pertussis vaccine antigens (aP antigens) (aP antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pertussis vaccine antigens (aP antigens) (aP antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call